The impact of carcinoma in situ in ureteral margins during radical cystectomy: A case-controlled study
•Carcinoma in situ in ureteral margins is a poor prognostic factor.•Achieving negative ureteral margins through the frozen section analysis should be recommended.•In addition, the upper urinary tract of carcinoma in situ in ureteral margins patients should be particularly monitored. The presence of...
Gespeichert in:
Veröffentlicht in: | Urologic oncology 2021-08, Vol.39 (8), p.497.e1-497.e8 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Carcinoma in situ in ureteral margins is a poor prognostic factor.•Achieving negative ureteral margins through the frozen section analysis should be recommended.•In addition, the upper urinary tract of carcinoma in situ in ureteral margins patients should be particularly monitored.
The presence of carcinoma in situ (Cis) in association with bladder cancer is associated with a poor prognosis. However, the prognosis associated with the presence of Cis in ureteral margins (CUM) during radical cystectomy has been poorly defined.
To assess the prognosis associated with the presence of Cis in ureteral margins in patients with pM0 bladder cancer who have not undergone neoadjuvant chemotherapy.
A retrospective case-control study was conducted between 2001 and 2016 using data from one academic center in France.
From 1,450 radical cystectomies, 122 patients (case) who had CUM were matched according to age, sex, pTNM stage and urinary diversion method with a population sample of 122 patients (controls) who did not have Cis in ureteral margins during radical cystectomy.
The survival analysis was performed by Kaplan-Meier using a (95%) CI. Multivariate Cox regression analysis was used to test the effect of CUM on cancer-specific survival. Recurrence-free survival was defined as a recurrence of urothelial carcinoma in the upper urinary tract.
The mean follow-up period was 55.43 ± 39.6 months. The rate of Cis in the bladder in the CUM cases group was evaluated at 11.47%. The median overall and specific survival was inferior in the CUM cases group estimated at 43.3 [35.33-56.93] months, 52.43 [42.16-68.93] months respectively compared to the control group with a significant difference (P= 0.001, P= 0.0039). The cumulative probability of urothelial recurrence-free survival was decreased in the case group compared with the control group (63.9% vs. 92.6%, P = 0.0001).
Multivariate analysis shown that urothelial recurrence was associated with CUM [(P |
---|---|
ISSN: | 1078-1439 1873-2496 |
DOI: | 10.1016/j.urolonc.2021.01.028 |